Talus
Facts
- HQ
- Seattle, USA
- Sectors
- Biotechnology, Drug discovery, Healthcare
- Stage
- Seed
Is this your organization? Claim it
GeekWire Awards Health Innovation Finalists Spotlight Cancer-Fighting Biotechs Including Archon Biosciences with $20M AI-Driven Protein Therapy
The GeekWire Awards finalists for Health Innovation of the Year primarily consist of companies developing advanced cancer-fighting technologies, alongside startups improving healthcare management. Notable finalists include Archon Biosciences, which recently secured $20 million to develop AI-optimized protein therapies, Fred Hutch Cancer Center, and others.
Flexe Names Pirasenna Thiyagarajan CTO; Talus Bioscience Appoints Gaelle Mercenne Amid $11.2M Funding; Vouched Adds David McGrath as Sales VP
Flexe appointed Pirasenna Thiyagarajan as chief technology and product officer following CTO David Glick's departure. Talus Bioscience hired Gaelle Mercenne as head of biology after securing $11.2 million in funding, while Vouched named David McGrath as vice president of sales amid leadership changes.
Pack Ventures Seeks $30M for Second Fund to Invest in University of Washington-Linked Startups
Pack Ventures, a venture capital fund focused on University of Washington-linked startups, raised $5 million for its first fund and is now aiming to raise $30 million for a second fund to expand its investments. The firm has established a preferred partnership with UW and co-invests with other Seattle VCs in companies across life sciences, software, and healthcare sectors.
See all 5 stories, episodes and videos about Talus.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events